134 related articles for article (PubMed ID: 12489987)
21. N-linked glycosylation of CXCR4 masks coreceptor function for CCR5-dependent human immunodeficiency virus type 1 isolates.
Chabot DJ; Chen H; Dimitrov DS; Broder CC
J Virol; 2000 May; 74(9):4404-13. PubMed ID: 10756055
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of a novel single-cycle recombinant-virus assay to determine human immunodeficiency virus type 1 coreceptor tropism.
Whitcomb JM; Huang W; Fransen S; Limoli K; Toma J; Wrin T; Chappey C; Kiss LD; Paxinos EE; Petropoulos CJ
Antimicrob Agents Chemother; 2007 Feb; 51(2):566-75. PubMed ID: 17116663
[TBL] [Abstract][Full Text] [Related]
23. The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12 binding and signaling and X4 HIV-1 viral infectivity.
Huskens D; Princen K; Schreiber M; Schols D
Virology; 2007 Jul; 363(2):280-7. PubMed ID: 17331556
[TBL] [Abstract][Full Text] [Related]
24. Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
Mild M; Esbjörnsson J; Fenyö EM; Medstrand P
J Virol; 2007 Apr; 81(7):3369-76. PubMed ID: 17251288
[TBL] [Abstract][Full Text] [Related]
25. Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies.
Nabatov AA; Pollakis G; Linnemann T; Kliphius A; Chalaby MI; Paxton WA
J Virol; 2004 Jan; 78(1):524-30. PubMed ID: 14671134
[TBL] [Abstract][Full Text] [Related]
26. HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use.
Karlsson I; Antonsson L; Shi Y; Karlsson A; Albert J; Leitner T; Olde B; Owman C; Fenyö EM
AIDS; 2003 Dec; 17(18):2561-9. PubMed ID: 14685050
[TBL] [Abstract][Full Text] [Related]
27. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
[TBL] [Abstract][Full Text] [Related]
28. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
[TBL] [Abstract][Full Text] [Related]
29. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
[TBL] [Abstract][Full Text] [Related]
30. Protection of neutralization epitopes in the V3 loop of oligomeric human immunodeficiency virus type 1 glycoprotein 120 by N-linked oligosaccharides in the V1 region.
Losman B; Bolmstedt A; Schønning K; Björndal A ; Westin C; Fenyö EM; Olofsson S
AIDS Res Hum Retroviruses; 2001 Jul; 17(11):1067-76. PubMed ID: 11485624
[TBL] [Abstract][Full Text] [Related]
31. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
LaBonte JA; Madani N; Sodroski J
J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
[TBL] [Abstract][Full Text] [Related]
32. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
Agrawal L; Lu X; Qingwen J; VanHorn-Ali Z; Nicolescu IV; McDermott DH; Murphy PM; Alkhatib G
J Virol; 2004 Mar; 78(5):2277-87. PubMed ID: 14963124
[TBL] [Abstract][Full Text] [Related]
33. Preferential use of CXCR4 by R5X4 human immunodeficiency virus type 1 isolates for infection of primary lymphocytes.
Yi Y; Shaheen F; Collman RG
J Virol; 2005 Feb; 79(3):1480-6. PubMed ID: 15650174
[TBL] [Abstract][Full Text] [Related]
34. Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1.
Polzer S; Dittmar MT; Schmitz H; Meyer B; Müller H; Kräusslich HG; Schreiber M
Glycobiology; 2001 Jan; 11(1):11-9. PubMed ID: 11181557
[TBL] [Abstract][Full Text] [Related]
35. Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.
Hatse S; Princen K; Gerlach LO; Bridger G; Henson G; De Clercq E; Schwartz TW; Schols D
Mol Pharmacol; 2001 Jul; 60(1):164-73. PubMed ID: 11408611
[TBL] [Abstract][Full Text] [Related]
36. Bioinformatic prediction programs underestimate the frequency of CXCR4 usage by R5X4 HIV type 1 in brain and other tissues.
Mefford ME; Gorry PR; Kunstman K; Wolinsky SM; Gabuzda D
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1215-20. PubMed ID: 18788913
[TBL] [Abstract][Full Text] [Related]
37. Increased neutralization sensitivity of recently emerged CXCR4-using human immunodeficiency virus type 1 strains compared to coexisting CCR5-using variants from the same patient.
Bunnik EM; Quakkelaar ED; van Nuenen AC; Boeser-Nunnink B; Schuitemaker H
J Virol; 2007 Jan; 81(2):525-31. PubMed ID: 17079299
[TBL] [Abstract][Full Text] [Related]
38. Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures.
Antell GC; Dampier W; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; Schwartz G; Hershberg U; Krebs FC; Wigdahl B
Retrovirology; 2016 May; 13(1):32. PubMed ID: 27143130
[TBL] [Abstract][Full Text] [Related]
39. Chemokine signaling and HIV-1 fusion mediated by macrophage CXCR4: implications for target cell tropism.
Collman RG; Yi Y; Liu QH; Freedman BD
J Leukoc Biol; 2000 Sep; 68(3):318-23. PubMed ID: 10985246
[TBL] [Abstract][Full Text] [Related]
40. Statistical correlation of nonconservative substitutions of HIV gp41 variable amino acid residues with the R5X4 HIV-1 phenotype.
Pacheco-Martínez E; Figueroa-Medina E; Villarreal C; Cocho G; Medina-Franco JL; Méndez-Lucio O; Huerta L
Virol J; 2016 Feb; 13():28. PubMed ID: 26879054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
